Carregant...
Preferential enhancement of older human T cell cytokine generation, Chemotaxis, proliferation and survival by lenalidomide
Lenalidomide, an analog of thalidomide, modified responses of stimulated T cells from healthy young (ages 21–40 years) and old (≥age 65 years) subjects. At 0.03 μM to 1 μM, lenalidomide enhanced generation of IL-2 and IFN-γ by T cell receptor-stimulated T cells of young subjects up to respective max...
Guardat en:
| Publicat a: | Clin Immunol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4642720/ https://ncbi.nlm.nih.gov/pubmed/21130040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2010.11.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|